top of page
2covidRolledMagazine copy.jpg

Sofia 2 Sars-Cov-2AD CAMPAIGN

Testing during a pandemic.

Tracking the virus is as important as testing for it.




Quidel Corporation was granted Emergency Use Authorization (EUA) for its Sofia SARS Antigen Fluorescent Immunoassay (FIA). The Sofia SARS Antigen FIA, with the Sofia 2 and Sofia analyzers, provides automated and objective results in 15 minutes, allowing for COVID-19 testing of symptomatic patients within the first five days of symptoms and asymptomatic patients when tested serially.

Brook-Schwartz+ suggested a series of ads focusing on testing for Covid-19, not only for Covid-19 testing, but the devices ability for wireless surveillance testing and reporting.

in 2020 Quidel Corporation witnessed a 211% increase in sales associated with Covid-19

We can do this for you.

bottom of page